Danaher Corp (DHR)

$238.37 +3.37 (1.43%)
Market Cap 168.37B
Revenue (ttm) 23.88B
Net Income (ttm) 3.90B
EPS (ttm) N/A
PE Ratio 30.48
Forward PE 28.04
Profit Margin 16.33%
Debt to Equity Ratio 0.33
Volume 2,536,100
Avg Vol 3,339,720
Day's Range N/A - N/A
Shares Out 706.35M
Stochastic %K 84%
Beta 0.89
Analysts Strong Sell
Price Target $260.57

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
catacal_
catacal_ Jan. 9 at 8:00 PM
$DHR CATALYST: J.P. Morgan Healthcare Conference is happening on Tue. Jan. 13 at 2:15 PM. Don't get blindsided by upcoming catalysts. Track this catalyst and more at: https://www.catacal.com/catalyst/jp-morgan-healthcare-conference-6 $SPY $QQQ
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 3:48 AM
$DHR Share Price: $235.00 Contract Selected: Jan 30, 2026 $235 Calls Buy Zone: $6.46 – $7.98 Target Zone: $11.08 – $13.55 Potential Upside: 62% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FlaMeZ907
FlaMeZ907 Jan. 7 at 4:44 PM
$DHR No such thing as a quadruple bottom. ⚓️ Who just bought 3? If the shares dump -10% today, we're making thousands 🧻
1 · Reply
FlaMeZ907
FlaMeZ907 Jan. 7 at 4:09 PM
$DHR I never heard of this company before, so it's gonna take a dump 💩
1 · Reply
OptionRunners
OptionRunners Jan. 6 at 6:21 PM
$DHR $235+, well off highs of $240+ this morning. Calls are $4.50 now.
0 · Reply
JeanetteStern139
JeanetteStern139 Jan. 6 at 4:43 PM
$BA $DHR $KLAC $PDD $TD Well reasoned
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Jan. 5 at 11:02 AM
$AMZN – Evercore Reiterates Outperform | PT $335 Rufus AI Impact: Amazon’s AI shopping assistant (Rufus) drove +$10B GMV in 2025 across 250M users. Customers using Rufus were 60% more likely to complete a purchase. Agentic Commerce Potential: Full rollout of features like AutoBuy, Predictive Bundling, and personalized recommendations could materially expand TAM, similar to the mobile internet revolution in online retail. Revenue Upside: Estimated boost of $56B retail GMV (4.4%) by 2028. AI-guided shopping increases ad efficiency, potentially adding $4B ad revenue (3%) by 2028. Operating Income Impact: Total operating income could rise $6.8B (4.6%) by 2028 from Agentic adoption. Takeaway: Agentic Commerce strengthens both retail and ad revenue streams, countering concerns of cannibalization and creating a long-term ROAI lever. Full analysis here! It's free👉 @StockAnalyst_SA $PANW $PFE $DHR $CVX
0 · Reply
OptionRunners
OptionRunners Dec. 30 at 8:30 PM
$DHR buyer of the January 16th 2026 $235 calls 1,000 times for $2.89
0 · Reply
TechTraderGrok
TechTraderGrok Dec. 29 at 11:14 PM
Bought $DHR at $230.68. From Grok: "Hold LONG—SunriseTrader holds "let it rides" post-ex-div, ChartMill bullish setup, analysts $243-270 PTs amid year-end strength." https://www.techtrader.ai/grokwall/?post=15940&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
OnlyFibs
OnlyFibs Dec. 28 at 2:48 AM
$DHR prints a series of Higher Lows into the $232 supply wall. The post-COVID inventory clearance is finally done, and the 0.56 put/call ratio confirms that no one wants to be short this lifecycle. The Setup: Textbook weekly trendline reclaim. We are wedged at the apex, waiting for that volume "push" through $233. Bull Level: A high-volume move through $233.96 clears the air for a fast gap-fill into the $258 yearly highs. Bear Risk: The absolute Line in the Sand is $204.32. Break that and the recovery resets. Catalyst: Jan 28th earnings are the next massive trigger for the new 6% core revenue expansion. 🚢📉 #hovdid
0 · Reply
Latest News on DHR
The Big 3: BA, DHR, DG

Jan 8, 2026, 1:05 PM EST - 3 days ago

The Big 3: BA, DHR, DG

BA DG

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 8, 2026, 8:00 AM EST - 3 days ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Danaher to Present at J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:15 PM EST - 6 days ago

Danaher to Present at J.P. Morgan Healthcare Conference

Top 15 High-Growth Dividend Stocks For January 2026

Jan 2, 2026, 7:44 PM EST - 8 days ago

Top 15 High-Growth Dividend Stocks For January 2026

ACN APH AVGO BMI CDW CMCSA DPZ

The Value Traps Of The REIT Sector

Dec 27, 2025, 8:50 AM EST - 15 days ago

The Value Traps Of The REIT Sector

ABNB BXP HST ILPT RMR SLG SVC

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:48 AM EST - 18 days ago

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 17, 2025, 7:30 AM EST - 25 days ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value

Dec 10, 2025, 4:38 AM EST - 4 weeks ago

Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value

Danaher Announces Quarterly Dividend

Dec 9, 2025, 4:15 PM EST - 4 weeks ago

Danaher Announces Quarterly Dividend

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

Dec 4, 2025, 12:15 PM EST - 5 weeks ago

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

DX HSY NLY BMEZ UTG

3 More Good Stocks to Invest In After Earnings

Nov 18, 2025, 4:29 PM EST - 7 weeks ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA

Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 8:28 AM EST - 7 weeks ago

Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 2 months ago

The Big 3: TMO, DHR, VLO

TMO VLO

Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 2 months ago

Danaher to Present at Jefferies Global Healthcare Conference

Top 15 High-Growth Dividend Stocks For November 2025

Nov 1, 2025, 11:00 PM EDT - 2 months ago

Top 15 High-Growth Dividend Stocks For November 2025

ACN APH AWK BMI CHH CMCSA CTAS

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 30, 2025, 4:10 PM EDT - 2 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Oct 27, 2025, 7:53 PM EDT - 2 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 26, 2025, 5:50 PM EDT - 2 months ago

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Oct 24, 2025, 11:52 AM EDT - 2 months ago

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Oct 22, 2025, 1:01 PM EDT - 2 months ago

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Danaher: Regaining Growth Momentum

Oct 22, 2025, 10:49 AM EDT - 2 months ago

Danaher: Regaining Growth Momentum

Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment

Oct 22, 2025, 8:10 AM EDT - 2 months ago

Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 11:14 AM EDT - 2 months ago

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Oct 21, 2025, 10:55 AM EDT - 2 months ago

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Oct 21, 2025, 7:01 AM EDT - 2 months ago

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 2 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum

Danaher Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 2 months ago

Danaher Reports Third Quarter 2025 Results

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 16, 2025, 10:18 PM EDT - 3 months ago

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Danaher Stock: Monopoly Margins, Discounted Price

Oct 15, 2025, 10:25 AM EDT - 3 months ago

Danaher Stock: Monopoly Margins, Discounted Price

4 Stocks That Aren't Too Hot to Buy Right Now

Oct 6, 2025, 2:45 PM EDT - 3 months ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU

Danaher: Balanced Portfolio With Upside Potential In 2026

Oct 1, 2025, 6:33 AM EDT - 3 months ago

Danaher: Balanced Portfolio With Upside Potential In 2026

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 23, 2025, 4:15 PM EDT - 3 months ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Analysts' Top S&P 500 Stocks to Buy Now

Sep 11, 2025, 2:26 PM EDT - 4 months ago

Analysts' Top S&P 500 Stocks to Buy Now

HWM SPGI

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

Sep 10, 2025, 8:31 AM EDT - 4 months ago

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Sep 5, 2025, 8:39 PM EDT - 4 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 4 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX GRAL ILMN IONS MRNA RGEN

Danaher Stock Closes Near Day's High After Key Trading Signal

Aug 4, 2025, 7:13 AM EDT - 5 months ago

Danaher Stock Closes Near Day's High After Key Trading Signal

Danaher Appoints Jonathan Leiken as General Counsel

Jul 31, 2025, 4:15 PM EDT - 5 months ago

Danaher Appoints Jonathan Leiken as General Counsel

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Jul 24, 2025, 8:08 PM EDT - 6 months ago

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Danaher Q2 2025 Update

Jul 24, 2025, 3:30 PM EDT - 6 months ago

Danaher Q2 2025 Update

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

Jul 23, 2025, 9:50 AM EDT - 6 months ago

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 1:18 PM EDT - 6 months ago

Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript

Cramer's Stop Trading: Danaher

Jul 22, 2025, 10:33 AM EDT - 6 months ago

Cramer's Stop Trading: Danaher

Danaher lifts annual profit view on strength in diagnostics, names new CFO

Jul 22, 2025, 7:51 AM EDT - 6 months ago

Danaher lifts annual profit view on strength in diagnostics, names new CFO

Danaher Announces Transition Plan for Chief Financial Officer

Jul 22, 2025, 6:02 AM EDT - 6 months ago

Danaher Announces Transition Plan for Chief Financial Officer

Danaher Reports Second Quarter 2025 Results

Jul 22, 2025, 6:00 AM EDT - 6 months ago

Danaher Reports Second Quarter 2025 Results

45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs

Jul 17, 2025, 9:14 AM EDT - 6 months ago

45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs

AEP AGNC ALL FAF FLMI GDEN JAAA

Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside

Jun 30, 2025, 4:23 AM EDT - 6 months ago

Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside

catacal_
catacal_ Jan. 9 at 8:00 PM
$DHR CATALYST: J.P. Morgan Healthcare Conference is happening on Tue. Jan. 13 at 2:15 PM. Don't get blindsided by upcoming catalysts. Track this catalyst and more at: https://www.catacal.com/catalyst/jp-morgan-healthcare-conference-6 $SPY $QQQ
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 3:48 AM
$DHR Share Price: $235.00 Contract Selected: Jan 30, 2026 $235 Calls Buy Zone: $6.46 – $7.98 Target Zone: $11.08 – $13.55 Potential Upside: 62% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FlaMeZ907
FlaMeZ907 Jan. 7 at 4:44 PM
$DHR No such thing as a quadruple bottom. ⚓️ Who just bought 3? If the shares dump -10% today, we're making thousands 🧻
1 · Reply
FlaMeZ907
FlaMeZ907 Jan. 7 at 4:09 PM
$DHR I never heard of this company before, so it's gonna take a dump 💩
1 · Reply
OptionRunners
OptionRunners Jan. 6 at 6:21 PM
$DHR $235+, well off highs of $240+ this morning. Calls are $4.50 now.
0 · Reply
JeanetteStern139
JeanetteStern139 Jan. 6 at 4:43 PM
$BA $DHR $KLAC $PDD $TD Well reasoned
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Jan. 5 at 11:02 AM
$AMZN – Evercore Reiterates Outperform | PT $335 Rufus AI Impact: Amazon’s AI shopping assistant (Rufus) drove +$10B GMV in 2025 across 250M users. Customers using Rufus were 60% more likely to complete a purchase. Agentic Commerce Potential: Full rollout of features like AutoBuy, Predictive Bundling, and personalized recommendations could materially expand TAM, similar to the mobile internet revolution in online retail. Revenue Upside: Estimated boost of $56B retail GMV (4.4%) by 2028. AI-guided shopping increases ad efficiency, potentially adding $4B ad revenue (3%) by 2028. Operating Income Impact: Total operating income could rise $6.8B (4.6%) by 2028 from Agentic adoption. Takeaway: Agentic Commerce strengthens both retail and ad revenue streams, countering concerns of cannibalization and creating a long-term ROAI lever. Full analysis here! It's free👉 @StockAnalyst_SA $PANW $PFE $DHR $CVX
0 · Reply
OptionRunners
OptionRunners Dec. 30 at 8:30 PM
$DHR buyer of the January 16th 2026 $235 calls 1,000 times for $2.89
0 · Reply
TechTraderGrok
TechTraderGrok Dec. 29 at 11:14 PM
Bought $DHR at $230.68. From Grok: "Hold LONG—SunriseTrader holds "let it rides" post-ex-div, ChartMill bullish setup, analysts $243-270 PTs amid year-end strength." https://www.techtrader.ai/grokwall/?post=15940&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
OnlyFibs
OnlyFibs Dec. 28 at 2:48 AM
$DHR prints a series of Higher Lows into the $232 supply wall. The post-COVID inventory clearance is finally done, and the 0.56 put/call ratio confirms that no one wants to be short this lifecycle. The Setup: Textbook weekly trendline reclaim. We are wedged at the apex, waiting for that volume "push" through $233. Bull Level: A high-volume move through $233.96 clears the air for a fast gap-fill into the $258 yearly highs. Bear Risk: The absolute Line in the Sand is $204.32. Break that and the recovery resets. Catalyst: Jan 28th earnings are the next massive trigger for the new 6% core revenue expansion. 🚢📉 #hovdid
0 · Reply
TechTraderGrok
TechTraderGrok Dec. 26 at 9:12 PM
Sold $DHR at $230.46 (+6.7%). From Grok: "Exit long DHR near resistance at 235 after strong run-up from 215.79 entry, locking in gains amid overbought signals and no fresh catalysts, with next earnings around late January 2026." https://www.techtrader.ai/grokwall/?post=15932&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Neahrain8
Neahrain8 Dec. 24 at 4:55 PM
$NEE $ANET $VSNTV $BA $DHR I know it.
0 · Reply
StreamSniper
StreamSniper Dec. 24 at 3:49 PM
$DHR Strategic optionality narrows unless resilience of demand as cyclical tailwinds fade, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 3:26 PM
Can $DHR keep growing on biotech strength — or is this peak momentum? 🔬 Biotechnology core revenues rose 6.5% in Q3 2025 on strong bioprocessing demand, and approximately 5% growth is expected in Q4, keeping this segment firmly in the driver’s seat. Find out if biotech can keep powering DHR’s growth 👉 https://www.zacks.com/stock/news/2806231/will-strength-in-biotechnology-unit-continue-to-drive-danahers-growth?cid=sm-stocktwits-2-2806231-teaser-25426&ADID=SYND_STOCKTWITS_TWEET_2_2806231_TEASER_25426
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Dec. 18 at 1:33 PM
Biotech revolution is here, everyone eyes CRISPR stars — but real money in tools. Gold rush: picks and shovels. Biotech "shovels": $ILMN: Sequencing monopoly $TMO: Lab equipment giant $PACB: Long-read leader $DHR: Life science tools $BECT: Diagnostic king
0 · Reply
Arunas1
Arunas1 Dec. 17 at 6:50 PM
$DHR fell out of the channel probably $180 - $199 next. Sorry
1 · Reply
stockrandd
stockrandd Dec. 16 at 10:14 PM
$MRNA $VRTX $DHR $TNXP Have you heard about $BHST Are you Bullish? https://www.youtube.com/watch?v=VCRFmrw7nhQ
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:22 PM
Wells Fargo updates rating for Danaher ( $DHR ) to Equal-Weight, target set at 230 → 240.
0 · Reply
parcha
parcha Dec. 15 at 3:57 PM
$DHR Wells Fargo raised its price target on Club name Danaher to $240 from $230 and kept its hold rating. The life sciences company is turning the corner. It has to do with the next cycle, which has finally come because of stabilization in health-care spending. Danaher was one of the seven out-of-favor stocks to buy that I identified in Friday’s Monthly Meeting for Club members. https://www.cnbc.com/2025/12/15/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html
0 · Reply
hoganbear
hoganbear Dec. 10 at 7:39 PM
$DHR OH FUCK YES!!!
0 · Reply
ripster47
ripster47 Dec. 10 at 11:58 AM
How To Find & Trade A+ #Earnings Setups $SBUX $LOGI $DHR @ripster47 | @tenet_research | @TenetCharts https://x.com/i/status/1998573506280534066
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Dec. 9 at 2:13 PM
$DHR Danny Hur ALWAYS disappoints
1 · Reply